大麻 (CBD) 可以帮助腰部疼痛吗?
Bartłomiej Kulesza1, Marek Mazurek2, Jacek Kurzepa1
1Department of Medical Chemistry, Medical University, Lublin, Poland.
Annals of agricultural and environmental medicine : AAEM
|September 29, 2023
概括
Cannabidiol (CBD) 对于急性腰部疼痛缓解的证据有限,与安慰剂无明显的优势. 虽然一些研究表明慢性腰部疼痛有潜在的益处,但需要更严格的研究.
科学领域:
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
- 大麻素研究 研究 大麻素研究
背景情况:
- 腰部疼痛 (LBP) 是导致残疾的主要原因,药物治疗的有效性有限.
- 大麻的一种成分大麻二醇 (CBD) 由于其一般的安全性和可用性,越来越多地用于LBP.
- 对于LBP的现有治疗方法往往有显著的副作用,需要新的治疗方法.
研究的目的:
- 进行关于大麻二醇 (CBD) 作为急性和慢性腰部疼痛的唯一药物的作用的叙述性审查.
- 评估CBD在治疗腰部疼痛方面的有效性目前的证据基础.
主要方法:
- 使用PubMed/MEDLINE进行了系统的文献搜索,遵循PRISMA指南.
- 包括在过去30年内发表的文章.
- 分析了所有符合纳入标准的研究类型,最终纳入了10项研究.
主要成果:
- 目前,支持CBD治疗急性腰痛的有效性的证据不足.
- 一项临床试验表明,CBD和安慰剂在急性LBP中没有显著差异.
- 大多数审查的研究集中在慢性LBP上,初步发现表明大麻素的潜在益处,尽管缺乏强有力的证据.
结论:
- 缺乏关于CBD在治疗急性腰部疼痛方面的有效性的明确证据.
- 虽然初步数据表明慢性腰部疼痛有潜在的益处,但高质量的随机对照试验对于证实这些发现至关重要.
- 需要进一步的严格研究来确定CBD在腰部疼痛管理中的作用.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
300
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
300
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Local Anesthetics: Clinical Application as Spinal Anesthesia
664
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
664
Drugs for Treatment of Constipation-Predominant IBS
197
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
197
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
224
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
224
Anxiolytic Drugs: Benzodiazepines and Buspirone
851
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
851


